Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lymphangioleiomyomas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03062943
What this trial is testing

Nintedanib for LymphAngioleioMyomatosis (LAM)

Who this might be right for
Lymphangioleiomyomatosis
IRCCS Multimedica 30
Early research (Phase 1)Looking for participantsNCT06889168
What this trial is testing

Evaluating the Long-term Safety and Tolerability of Imatinib in Patients With Lymphangioleiomyomatosis (LAM)

Who this might be right for
Lymphangioleiomyomatosis (LAM)Lymphangioleiomyomatosis
Columbia University 20
Not applicableLooking for participantsNCT06160310
What this trial is testing

Tuberous Sclerosis Complex and Lymphangioleiomyomatosis Pregnancy Registry (TSC-LAM Registry)

Who this might be right for
Tuberous Sclerosis ComplexLymphangioleiomyomatosis
David M. Ritter 300
Not applicableStudy completedNCT00005486
What this trial is testing

Lymphangioleiomyomatosis (LAM) Registry

Who this might be right for
Lung DiseasesLymphangiomyomatosis
National Heart, Lung, and Blood Institute (NHLBI)
Not applicableUnknownNCT04577937
What this trial is testing

Sleep Patterns in Patients Affected by Lymphangioleiomiomatosis

Who this might be right for
LymphangioleiomyomatosisSleep DisorderSleep Apnea Syndromes+1 more
dr. Stefano Nava 15
Testing effectiveness (Phase 2)Looking for participantsNCT01799538
What this trial is testing

Nebulized or Inhaled Albuterol for Lymphangioleiomyomatosis

Who this might be right for
Lymphangioleiomyomatosis
National Heart, Lung, and Blood Institute (NHLBI) 100
Not applicableEnrolling By InvitationNCT05727852
What this trial is testing

Breath Analysis and Arterial Stiffness in Patients With Respiratory Diseases

Who this might be right for
Chronic Respiratory DiseasesCystic FibrosisLymphangioleiomyomatosis+4 more
I.M. Sechenov First Moscow State Medical University 400
Early research (Phase 1)Study completedNCT04388371
What this trial is testing

Glutamine PET Imaging in LAM

Who this might be right for
Lymphangioleiomyomatosis (LAM)
Vanderbilt University Medical Center 5
Early research (Phase 1)Study completedNCT02116712
What this trial is testing

The Tolerability of Saracatinib in Subjects With Lymphangioleiomyomatosis (LAM) (SLAM-1)

Who this might be right for
Pulmonary Lymphangioleiomyomatosis
Tony Eissa 9
Testing effectiveness (Phase 2)Study completedNCT01353209
What this trial is testing

Letrozole for Lymphangioleiomyomatosis

Who this might be right for
Lymphangioleiomyomatosis
University of Cincinnati 17
Testing effectiveness (Phase 2)Active Not RecruitingNCT05467397
What this trial is testing

Feasibility of [11C]Acetate-PET in LAM and TSC

Who this might be right for
LymphangioleiomyomatosisTuberous Sclerosis Complex
Brigham and Women's Hospital 7
Not applicableLooking for participantsNCT03193892
What this trial is testing

A National Registry on Chinese Patients With Lymphangioleiomyomatosis

Who this might be right for
Pulmonary Function
Peking Union Medical College Hospital 1,500
Not applicableStudy completedNCT02859194
What this trial is testing

The Effect of Lt to Rt Shunt Using Veno-veno-arterial Extracorporeal Membrane Oxygenation (ECMO) on Coronary Oxygenation in Lung Transplantation Patients

Who this might be right for
Interstitial Pulmonary Fibrosis ARDSCOPD (Chronic Obstructive Pulmonary Disease)Bronchiectasis+3 more
Yonsei University 10
Testing effectiveness (Phase 2)Study completedNCT00457964
What this trial is testing

RAD001 Therapy of Angiomyolipomata in Patients With TS Complex and Sporadic LAM

Who this might be right for
Tuberous SclerosisLymphangioleiomyomatosis
Children's Hospital Medical Center, Cincinnati 36
Not applicableStudy completedNCT02325505
What this trial is testing

Characterization of Patients With Tuberous Sclerosis Complex, Lymphangioleiomyomatosis and Angiomyolipoma

Who this might be right for
Tuberous SclerosisLymphangioleiomyomatosisAngiomyolipoma
InCor Heart Institute 200
Post-approval studies (Phase 4)Study completedNCT03525834
What this trial is testing

Safety and Efficacy of Everolimus (Afinitor®) in Chinese Adult Patients With Angiomyolipoma Associated With Tuberous Sclerosis Complex.

Who this might be right for
Renal Angiomyolipoma
Novartis Pharmaceuticals 40
Testing effectiveness (Phase 2)UnknownNCT05190627
What this trial is testing

Effect of Loratadine in Lymphangioleiomyomatosis

Who this might be right for
Lymphangioleiomyomatosis
Institut d'Investigació Biomèdica de Bellvitge 62
Not applicableStudy completedNCT05323370
What this trial is testing

Lymphangioleiomyomatosis, a Study on Cathepsin K

Who this might be right for
LymphangioleiomyomatosisTuberous Sclerosis Complex
University Hospital, Tours 19
Testing effectiveness (Phase 2)UnknownNCT00490789
What this trial is testing

Trial of Efficacy and Safety of Sirolimus in Tuberous Sclerosis and LAM

Who this might be right for
Tuberous SclerosisLymphangioleiomyomatosis
Cardiff University 14
Testing effectiveness (Phase 2)Study completedNCT02484664
What this trial is testing

COLA: A Pilot Clinical Trial of COX-2 Inhibition in LAM and TSC

Who this might be right for
Lymphangioleiomyomatosis (LAM)
Brigham and Women's Hospital 12
Next Page